Breast cancer microenvironments are enriched with inhibitory cytokines (TGF-β, IL-10), myeloid-derived suppressor cells (MDSCs), and cancer-associated fibroblasts (CAFs), which collectively limit immune infiltration and promote exhaustion [117]. The gene discussed is TGFB1; the disease is breast carcinoma.